IDO1 and neoplasm: Analysis of IDO1 DNA methylation in UALCAN showed a significant (p < 0.0001) decrease in promoter methylation in HNSCC tumor samples (n = 528) compared to the adjacent normal tissues (n = 50; Figure 5A).